Post-approval studies (Phase 4)WithdrawnNCT04241744What this trial is testingProspective Trial of Oral Vancomycin Therapy vs. Placebo for Prevention of CDIWho this might be right forCDI Creighton University
Testing effectiveness (Phase 2)Study completedNCT01925417What this trial is testingMicrobiota Restoration Therapy for Recurrent Clostridium Difficile-associated DiarrheaWho this might be right forRecurrent Clostridium Difficile Infection Rebiotix Inc. 34
Not applicableEnded earlyNCT01372943What this trial is testingHarnessing the Healthy Gut Microbiota to Cure Patients With Recurrent C. Difficile InfectionWho this might be right forClostridium Difficile Infection Queen's University 4
Not applicableNot Yet RecruitingNCT06702345What this trial is testingClostridioides Difficile Controlled Human Infection ModelWho this might be right forC. DifficileC. Difficile InfectionControlled Human Infection Leiden University Medical Center 60
Large-scale testing (Phase 3)Study completedNCT00106509What this trial is testingGT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C.Difficile - Associated DiarrheaWho this might be right forClostridium EnterocolitisPseudomembranous Colitis Genzyme, a Sanofi Company 520
Testing effectiveness (Phase 2)Ended earlyNCT03617445What this trial is testingFecal Microbiota Transplantation for C. Difficile Infection in Solid Organ Transplant RecipientsWho this might be right forClostridium Difficile Infection Recurrence University of Wisconsin, Madison 3
Large-scale testing (Phase 3)Ended earlyNCT01887912What this trial is testingStudy of a Candidate Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile InfectionWho this might be right forClostridium Difficile Infection Sanofi Pasteur, a Sanofi Company 9,302
Early research (Phase 1)Study completedNCT01551004What this trial is testingPhase I Trial of a Single Dose of CRS3123Who this might be right forClostridium Difficile Colitis National Institute of Allergy and Infectious Diseases (NIAID) 40
Large-scale testing (Phase 3)Study completedNCT00196794What this trial is testingGT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C. Difficile-Associated DiarrheaWho this might be right forClostridium EnterocolitisDiarrhea Genzyme, a Sanofi Company 520
Not applicableStudy completedNCT03848689What this trial is testingFQ Restriction for the Prevention of CDIWho this might be right forClostridium DifficileClostridium Difficile InfectionC Difficile Colitis University of Wisconsin, Madison 5,871
Testing effectiveness (Phase 2)Study completedNCT01782755What this trial is testingProbiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial (PROSPECT): A Feasibility Clinical TrialWho this might be right forVentilator Associated Pneumonia (VAP)Other InfectionsAntibiotic-Associated Diarrhea+5 more McMaster University 150
Not applicableStudy completedNCT02770326What this trial is testingSafety of Stool Transplant for Patients With Difficult to Treat C. Difficile InfectionWho this might be right forC. Difficile InfectionCancer Memorial Sloan Kettering Cancer Center 10
Large-scale testing (Phase 3)Ended earlyNCT03005379What this trial is testingMicrobiota or Placebo After Antimicrobial Therapy for Recurrent C. Difficile at Home (MATCH)Who this might be right forClostridium Difficile Infection VA Office of Research and Development 153
Large-scale testing (Phase 3)Looking for participantsNCT05330182What this trial is testingLMN-201 for Prevention of C. Difficile Infection RecurrenceWho this might be right forClostridioides Difficile Infection Lumen Bioscience, Inc. 375
Post-approval studies (Phase 4)Ended earlyNCT04626947What this trial is testingPrevention of Recurrent Clostridium Difficile Infection (CDI) in Patients With Inflammatory Bowel Disease (IBD).Who this might be right forInflammatory Bowel DiseasesUlcerative ColitisCrohn Disease+1 more David Binion, MD 19
Post-approval studies (Phase 4)WithdrawnNCT01552668What this trial is testingFidaxomicin to Prevent Clostridium Difficile ColonizationWho this might be right forClostridium Difficile Infection Washington University School of Medicine
Not applicableLooking for participantsNCT05389904What this trial is testingPre-emptive Prevention for Patients at High Risk for Hospital-onset Clostridioides DifficileWho this might be right forC. Difficile Brigham and Women's Hospital 300
Testing effectiveness (Phase 2)Study completedNCT03353506What this trial is testingLyophilized Fecal Transplant vs Lyophilized Fecal Filtrate in Recurrent C Diff InfectionWho this might be right forEnterocolitisRecurrent Clostridium Difficile Infection Dina Kao 11
Early research (Phase 1)Not Yet RecruitingNCT05852587What this trial is testingXylitol Use for Decolonization of C. Difficile in Patients With IBDWho this might be right forInflammatory Bowel DiseasesClostridioides Difficile Infection Brigham and Women's Hospital 99
Large-scale testing (Phase 3)Looking for participantsNCT06979609What this trial is testingSecondary Prevention of Clostridioides Difficile Using VancomycinWho this might be right forClostridioides Difficile InfectionClostridioides Difficile Infection RecurrenceClostridoides Difficile Associated Disease McGill University Health Centre/Research Institute of the McGill University Health Centre 300